Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Cash from Financing Activities came in at -$486274.0 in Q4 2025, down 1506.99% year-on-year from $34561.4 in Q4 2024, and down 280.89% quarter-over-quarter from $268829.0 in Q3 2025.
Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025) Analysis & Trends
Healthy Extracts' Cash from Financing Activities history runs 11 years deep, the most recent figure standing at -$486274.0 for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 1506.99% year-over-year to -$486274.0 in Q4 2025; TTM through Dec 2025 was -$186906.0, a 1.31% increase from a year earlier, with the FY2025 full-year figure at -$186906.0, up 1.31% from the prior year.
- Cash from Financing Activities slipped to -$486274.0 in Q4 2025 per HYEX's latest filing, from $268829.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $846880.0 in Q1 2021 and bottomed at -$486274.0 in Q4 2025.
- The 5-year median for Cash from Financing Activities is $35458.5 (2023), against an average of $69648.0.
- Across the five-year window, Cash from Financing Activities soared 3755.28% in 2023 and plunged 1506.99% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $77199.0 in 2021, then jumped by 79.7% to $138730.0 in 2022, then slumped by 159.52% to -$82574.0 in 2023, then jumped by 63.35% to -$30260.0 in 2024, then plunged by 1506.99% to -$486274.0 in 2025.
- Per Business Quant, the three latest HYEX Cash from Financing Activities figures stand at -$486274.0 (Q4 2025), $268829.0 (Q3 2025), and $83782.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -840.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -494.13 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.48 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -203.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -65.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -486,274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -486,274.00 |
| Dec 31, 2025 | -486,274.00 |
| Sep 30, 2025 | 268,829.00 |
| Sep 30, 2025 | 268,829.00 |
| Jun 30, 2025 | 83,782.00 |
| Jun 30, 2025 | 83,782.00 |
| Mar 31, 2025 | -53,243.00 |
| Mar 31, 2025 | -53,243.00 |
| Dec 31, 2024 | -30,260.00 |
| Dec 31, 2024 | -30,260.00 |
| Sep 30, 2024 | -100,109.00 |
| Sep 30, 2024 | -100,109.00 |
| Jun 30, 2024 | -108,166.00 |
| Jun 30, 2024 | -108,166.00 |
| Mar 31, 2024 | 49,146.00 |
| Mar 31, 2024 | 49,146.00 |
| Dec 31, 2023 | -82,574.00 |
| Dec 31, 2023 | -82,574.00 |
| Sep 30, 2023 | 21,771.00 |
| Sep 30, 2023 | 21,771.00 |